Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes | Clinical Trials | Clareo Health

Back to search

COMPLETED

Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes

ProLyPhy-GEP : Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes

NCT03597685•University Hospital, Montpellier

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Lymphoma Diffuse Large B-cell

Locations

France

Locations (1)

Uhmontpellier

Montpellier, France

Key Dates

Start Date

February 20, 2018

Primary Completion Date

December 31, 2018

Completion Date

January 31, 2019

Last Updated

April 18, 2019

Sponsors

Lead Sponsor

University Hospital, Montpellier

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 18, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions